Form D · Pharmaceuticals

Harmony Biosciences II, Inc.

Plymouth Meeting, PA · CIK 0001718575

Offering snapshot reported Aug 22, 2019 · SEC filing

Reported sold
$50M
Offering amount: $50M
Investors reported
30
Form D · investor count
Minimum accepted
$14K
Reported outside-investor minimum
First sale
Aug 9, 2019
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 22, 2019Initial$50,000,001No comparison30SEC filing
Jan 18, 2018Initial$25,000,000No comparison2SEC filing
Oct 6, 2017Initial$270,000,000No comparison29SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$1M
Finders' fees
$0
Form D file number
021-347211

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
OCTAGON CAPITAL GROUP, LLC173341

Source: Form D, filed Aug 22, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jeffrey Aronin Director
Octagon Capital Group, Llc Promoter
Martin Edwards Director
Wilbur Gantz Iii Director
Wilbur Gantz, Iii Director
Antonio Gracias Director
John Jacobs Director, Executive
Patrick Morris Executive
Jack Bech Nielsen Director
Darien Parhad Executive
Robert Repella Director, Executive
Aaron Royston Director
Juan Sabater Director
Andrew Serafin Executive
John Vittoria Executive
Dr. Andreas Wicki Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
630 W Germantown Pike Suite 215
Plymouth Meeting, PA, 19462